Clinical Reviews in Allergy & Immunology

, Volume 33, Issue 3, pp 199–203

Emerging Treatment of Atopic Dermatitis

Article

DOI: 10.1007/s12016-007-0043-6

Cite this article as:
Hsu, CJ. & Wang, LF. Clinic Rev Allerg Immunol (2007) 33: 199. doi:10.1007/s12016-007-0043-6

Abstract

Atopic dermatitis is a chronically relapsing eczematous disease of the skin. A wide range of therapeutic regimens has been used for atopic dermatitis. A better understanding of its pathogenesis will also lead to the development of novel approaches to treating this disease. This article reviews the recent advances in allergen-specific sublingual immunotherapy and therapy with antileukotriene drugs, probiotics, mycophenolate mofetil, leflunomide, and intermittent fluticasone propionate ointment, which the authors expect will be clinically useful therapies in the near future.

Keywords

Atopic dermatitis Sublingual immunotherapy Probiotic Leukotriene antagonists Mycophenolate mofetil Leflunomide Fluticasone propionate 

Abbreviations

AD

Atopic dermatitis

LTs

Leukotrienes

MMF

Mycophenolate mofetil

SLIT

Allergen-specific sublingual immunotherapy

FP

Fluticasone propionate

Copyright information

© Humana Press Inc. 2007

Authors and Affiliations

  1. 1.Department of DermatologyNational Taiwan University HospitalTaipeiRepublic of China

Personalised recommendations